Raymond J. Kelleher, MD, PhD

Dr Raymond J. Kelleher is the Managing Director at Cormorant Asset Management, overseeing investments in private and public companies across various therapeutic fields. Serving on the boards of Arkuda Therapeutics, BiVACOR, and ONK Therapeutics, he also acts as a board observer for Chroma Therapeutics, Umoja Biopharma, Interius BioTherapeutics, Garuda Therapeutics, and DTx Pharma. Dr Kelleher is a faculty member at Massachusetts General Hospital and Harvard Medical School, with research contributions recognized by prestigious national awards. He practices clinical neurology, specializing in neurodegenerative disorders, including Alzheimer’s disease.